Mesenchymal stem cells: a potential therapeutic strategy for neurodegenerative diseases

P Yao, L Zhou, L Zhu, B Zhou, Q Yu - European Neurology, 2020 - karger.com
Neurodegenerative disease is a kind of chronic, progressive nervous system disease
characterized by neuron degeneration or apoptosis. Current treatments cannot prevent the …

[HTML][HTML] Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases

Z Kovács, B Brunner, C Ari - Nutrients, 2021 - mdpi.com
Life expectancy of humans has increased continuously up to the present days, but their
health status (healthspan) was not enhanced by similar extent. To decrease enormous …

[HTML][HTML] Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ mouse

EC Genin, B Madji Hounoum, S Bannwarth… - Acta …, 2019 - Springer
Recently, we provided genetic basis showing that mitochondrial dysfunction can trigger
motor neuron degeneration, through identification of CHCHD10 encoding a mitochondrial …

[HTML][HTML] A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS

UG Vijayakumar, V Milla, MY Cynthia Stafford… - Frontiers in …, 2019 - frontiersin.org
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is an incurable
neurodegenerative condition, characterized by the loss of upper and lower motor neurons. It …

[HTML][HTML] Neuromuscular junction dismantling in amyotrophic lateral sclerosis

V Cappello, M Francolini - International journal of molecular sciences, 2017 - mdpi.com
Neuromuscular junction assembly and plasticity during embryonic, postnatal, and adult life
are tightly regulated by the continuous cross-talk among motor nerve endings, muscle fibers …

[HTML][HTML] Toward a glutamate hypothesis of frontotemporal dementia

A Benussi, A Alberici, E Buratti, R Ghidoni… - Frontiers in …, 2019 - frontiersin.org
Frontotemporal dementia (FTD) is a heterogenous neurodegenerative disorder,
characterized by diverse clinical presentations, neuropathological characteristics and …

[HTML][HTML] Fluid-based biomarkers for amyotrophic lateral sclerosis

LT Vu, R Bowser - Neurotherapeutics, 2017 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a highly heterogeneous disease with no effective
treatment. Drug development has been hampered by the lack of biomarkers that aid in early …

[HTML][HTML] A directional 3D neurite outgrowth model for studying motor axon biology and disease

XM Spijkers, S Pasteuning-Vuhman, JC Dorleijn… - Scientific reports, 2021 - nature.com
We report a method to generate a 3D motor neuron model with segregated and directed
axonal outgrowth. iPSC-derived motor neurons are cultured in extracellular matrix gel in a …

[HTML][HTML] Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders

A Aragón-González, PJ Shaw, L Ferraiuolo - International Journal of …, 2022 - mdpi.com
The blood–brain barrier (BBB) is a highly specialized and dynamic compartment which
regulates the uptake of molecules and solutes from the blood. The relevance of the …

[HTML][HTML] Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease

GF Makhaeva, SV Lushchekina, NP Boltneva… - Scientific reports, 2015 - nature.com
Alzheimer disease is a multifactorial pathology and the development of new multitarget
neuroprotective drugs is promising and attractive. We synthesized a group of original …